US Patent 9932597 Vectors for transgene expression
Patent 9932597 was granted and assigned to Adaptimmune on April, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+376 characters)
Article
Patent abstract
The present invention relates to a vector system involving replacement of a Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (WPRE) sequence with an unrelated short spacer sequence for efficient expression of nucleotides of interest in a retroviral vector system and methods of delivering and expressing nucleotides of interest to target cells.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
On Kan0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09932597 Vectors for transgene expression US Patent 9932597 Vectors for transgene expression
Infobox
Patent Number
099325970
Patent Number
99325970
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099325970
Date of Patent
April 3, 2018
0Patent Application Number
145232180
Date Filed
October 24, 2014
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09932597 Vectors for transgene expression
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09932597
Date of patent
April 3, 2018
Patent application number
14523218
Date Filed
October 24, 2014
Patent primary examiner
Find more entities like US Patent 9932597 Vectors for transgene expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
